VEXT — Vext Science Income Statement
0.000.00%
Last trade - 00:00- CA$61.92m
- CA$105.74m
- $36.00m
- 65
- 88
- 77
- 91
Annual income statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.2 | 37.2 | 35.4 | 34.8 | 36 |
| Cost of Revenue | |||||
| Gross Profit | 10 | 16.5 | 20.9 | 13.8 | 11.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22.6 | 30.3 | 26.3 | 47.5 | 47.8 |
| Operating Profit | 2.61 | 6.98 | 9.08 | -12.6 | -11.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.64 | 6.82 | 6.7 | 3.36 | -21.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.13 | 4.99 | 10.9 | 4.4 | -22.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.13 | 4.99 | 10.9 | 4.4 | -22.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 2.13 | 4.99 | 10.9 | 4.94 | -22.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.048 | 0.034 | 0.069 | -0.022 | -0.084 |